Bioglan rescue bid in final stage
Beleaguered biotechnology company Bioglan Pharma is in the last stage of rescue talks with US research group Quintiles Transnational Corp.
Beleaguered biotechnology company Bioglan Pharma is in the last stage of rescue talks with US research group Quintiles Transnational Corp.
The talks will secure a deal believed to give Quintiles a 30% share in Bioglan through new share issues and would force founder and chief executive Terry Sadler to dilute his 35% holding in the company.
The British biotechnology company saw its financial health fail last year when it attempted to acquire US competitor Bristol-Myers Squibb’s skincare operation for $765m.
The takeover bid failed, leaving Bioglan indebted. It still owes £105m to a consortium of banks led by Royal Bank of Scotland.
Earlier this week, the British company sold its Danish generic drug makers to a Scandinavian holding company for £1.2m, the proceeds of which will be used to pay off creditors. The buyer also agreed to take on the Danish subsidaries’ £500,00 debts.
Bioglan, whose market capitalisation was £577m at its peak, is now worth only £2m.
In the past decade, the professional services industry has transformed significantly. Digital disruptions, increased competition, and changing market ...
View resourceIn recent months, professional services firms are facing more pressure than ever to deliver value to clients. Often, clients look at the firms own inf...
View resourceIn a world of instant results and automated workloads, the potential for AP to drive insights and transform results is enormous. But, if you’re still ...
View resourceThe first phase of Making Tax Digital (MTD) saw the requirement for the digital submission of the VAT Return using compliant software. That’s now behi...
View resourceInsolvency statistics in the UK for the second quarter of 2023 were the highest since 2009 with 83% of them relating to small businesses Read More...
View articleThere were 6,342 recorded company insolvencies in Q2, reflecting a 9% increase compared to the number of insolvencies in Q1, and a 13% increase compar...
View articleThe survey paints a “brightening” picture of the global economy, according to the ACCA Read More...
View articleThe pandemic may have “distorted” some economic data Read More...
View articleAdvisory firms must offer a “more supportive” and holistic approach to clients amid the economic downturn Read More...
View articleHaving a clear plan and clean data to help optimise the use of scarce resources will be key for businesses Read More...
View articleThe Coronavirus Job Retention Scheme has supported millions of jobs amid the pandemic, but with the support measure set to end in September, how can a...
View articleShift from BBL debt to equity could pose wider business implications Read More...
View article